Facilitated By

San Antonio Medical Foundation

US stocks drop on lower odds for steep Fed rate cut

PROMISING THERAPY: Sangamo Therapeutics surged 9.5% after a test of a therapy that the biotech company is working on to combat hemophilia ...

Published